SELLAS Life Sciences Grou... (SLS)
NASDAQ: SLS
· Real-Time Price · USD
1.59
-0.07 (-4.22%)
At close: Jun 16, 2025, 3:59 PM
-4.22% (1D)
| Bid | 1.2 |
| Market Cap | 159.15M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -27.13M |
| EPS (ttm) | -0.36 |
| PE Ratio (ttm) | -4.43 |
| Forward PE | -4.3 |
| Analyst | n/a |
| Ask | 2.04 |
| Volume | 1,649,321 |
| Avg. Volume (20D) | 2,031,217 |
| Open | 1.70 |
| Previous Close | 1.66 |
| Day's Range | 1.58 - 1.71 |
| 52-Week Range | 0.77 - 2.12 |
| Beta | 2.27 |
11 months ago
+4.59%
SELLAS Life Sciences Group shares are trading high...
Unlock content with
Pro Subscription
2 months ago · seekingalpha.com
Sellas Life Sciences: A Hold For Now With Huge, But Uncertain, Near-Term CatalystSellas Life Sciences Group, Inc.'s stock has dropped significantly, with a Hold rating due to uncertainty around the final Phase 3 trial data for GPS in AML. Interim results for GPS are promising but ...